Kumaraguru Raja
Stock Analyst at Brookline Capital
(3.7)
Main Sectors:
Top Industries:
17 Stocks
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
INTS Intensity Therapeuti... | Upgrades: Buy | 3 | n/a | n/a | 1 | Aug 12, 2025 | |
PALI Palisade Bio | Maintains: Buy | 16 16 | 1.6 | 900% | 2 | May 13, 2025 | |
QNCX Quince Therapeutics | Initiates Coverage On: Buy | 9 | 1.65 | 445.45% | 1 | Dec 18, 2024 | |
SABS SAB Biotherapeutics | Initiates Coverage On: Buy | 8 | 2.05 | 290.24% | 1 | Jun 7, 2024 | |
FBRX Forte Biosciences | Initiates Coverage On: Buy | 100 | 15.49 | 545.58% | 2 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 1 | Dec 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 1 | Aug 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 150 | n/a | n/a | 2 | Jul 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 15 | 3.24 | 362.96% | 1 | Jun 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Buy | 9 | n/a | n/a | 1 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Buy | 21 | 4.63 | 353.56% | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Buy | 15 | n/a | n/a | 1 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Buy | 90 | 99.39 | -9.45% | 1 | Dec 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 290 310 | 3.8 | 8057.89% | 2 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 33600 | 4.9 | 685614.29% | 1 | Sep 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 320 | n/a | n/a | 1 | Mar 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 120 | n/a | n/a | 1 | Mar 25, 2021 |